AXGN logo

AxoGen (AXGN) EBITDA

Annual EBITDA

-$13.33 M
+$10.14 M+43.22%

December 31, 2023

Summary

Performance

1-Year Change

+43.22%

3-Year Change

+30.84%

5-Year Change

+34.47%

15-Year Change

-79.74%

AXGN EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

60.03%
AXGN annual EBITDA is higher than 60.03% of companies in Healthcare sector

High & Low

All-time High

$15.98 M
AXGN annual EBITDA is currently -183.41% below its historical high of $15.98 million

3-Year Low

-$23.47 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
AXGN previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 25, 2025
AXGN next annual earnings announcement is scheduled for Feb 25, 2025

OtherAXGNprofitabilitymetrics:

Annual Revenue

$159.01 M
AXGN annual revenue is $159.01 million

Annual Net Income

-$21.72 M
AXGN annual net profit is -$21.72 million

Annual EBIT

-$18.88 M
AXGN annual earnings before interest & taxes is -$18.88 million

Annual EPS

-$0.51
AXGN annual earnings per share is -$0.51

Quarterly EBITDA

$2.00 M
-$324.00 K-13.94%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+135.97%

5-Year Change

+141%

AXGN Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

78.04%
AXGN quarterly EBITDA is higher than 78.04% of companies in Healthcare sector

High & Low

All-time High

$16.09 M
AXGN quarterly EBITDA is currently -87.57% below its historical high of $16.09 million

3-Year Low

-$9.92 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AXGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 25, 2025
AXGN next earnings announcement is scheduled for Feb 25, 2025

OtherAXGNprofitabilitymetrics:

Quarterly Revenue

$48.64 M
AXGN quarterly revenue is $48.64 million

Quarterly Net Income

-$1.86 M
AXGN quarterly net profit is -$1.86 million

Quarterly EBIT

$35.00 K
AXGN quarterly earnings before interest & taxes is $35.00 thousand

Quarterly EPS

-$0.04
AXGN quarterly earnings per share is -$0.04

TTM EBITDA

$1.72 M
+$3.85 M+180.18%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+108.17%

5-Year Change

+106.54%

AXGN TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

77.45%
AXGN TTM EBITDA is higher than 77.45% of companies in Healthcare sector

High & Low

All-time High

$15.98 M
AXGN TTM EBITDA is currently -89.27% below its historical high of $15.98 million

3-Year Low

-$26.00 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AXGN previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 25, 2025
AXGN next earnings announcement is scheduled for Feb 25, 2025

OtherAXGNprofitabilitymetrics:

TTM Revenue

$180.86 M
AXGN TTM revenue is $180.86 million

TTM Net Income

-$14.31 M
AXGN TTM net profit is -$14.31 million

TTM EBIT

-$6.06 M
AXGN TTM earnings before interest & taxes is -$6.06 million

TTM EPS

-$0.32
AXGN TTM earnings per share is -$0.32

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$13.33 M
AXGN annual EBITDA is -$13.33 million

Annual Net Income

-$21.72 M
AXGN annual net profit is -$21.72 million

Annual Interest Expense

$2.83 M
AXGN annual interest expense is $2.83 million

Annual Income Tax

-
AXGN annual income tax value is unknown

Annual D&A

$5.55 M
AXGN annual depreciation & amortization is $5.55 million

AXGN EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+43.2%0.0%0.0%
3 y3 years+30.8%+136.0%+108.2%
5 y5 years+34.5%+141.0%+106.5%

AXGN EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+43.2%-13.9%+120.2%at high+106.6%
5 y5-yearat high+49.2%-13.9%+120.2%at high+106.5%
alltimeall time-183.4%+49.2%-87.6%+120.2%-89.3%+106.5%

AxoGen EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
$2.00 M(-13.9%)
$1.72 M(-180.2%)
Jun 2024
-
$2.32 M(-196.4%)
-$2.14 M(-78.5%)
Mar 2024
-
-$2.41 M(+1124.4%)
-$9.93 M(-25.5%)
Dec 2023
-$13.33 M(-43.2%)
-$197.00 K(-89.4%)
-$13.33 M(-23.5%)
Sep 2023
-
-$1.85 M(-66.1%)
-$17.42 M(-6.1%)
Jun 2023
-
-$5.46 M(-6.0%)
-$18.55 M(-4.2%)
Mar 2023
-
-$5.81 M(+35.7%)
-$19.36 M(-17.5%)
Dec 2022
-$23.47 M(+12.4%)
-$4.29 M(+43.6%)
-$23.47 M(+0.2%)
Sep 2022
-
-$2.98 M(-52.5%)
-$23.43 M(-9.9%)
Jun 2022
-
-$6.28 M(-36.7%)
-$26.00 M(+0.4%)
Mar 2022
-
-$9.92 M(+133.9%)
-$25.91 M(+24.1%)
Dec 2021
-$20.89 M(+8.4%)
-$4.24 M(-23.7%)
-$20.89 M(-0.5%)
Sep 2021
-
-$5.56 M(-10.2%)
-$20.99 M(+34.4%)
Jun 2021
-
-$6.19 M(+26.4%)
-$15.62 M(-7.2%)
Mar 2021
-
-$4.90 M(+12.8%)
-$16.82 M(-12.7%)
Dec 2020
-$19.27 M(-26.5%)
-$4.34 M(+2209.0%)
-$19.27 M(-8.9%)
Sep 2020
-
-$188.00 K(-97.5%)
-$21.16 M(-18.1%)
Jun 2020
-
-$7.39 M(+0.6%)
-$25.85 M(+4.4%)
Mar 2020
-
-$7.35 M(+18.0%)
-$24.75 M(-5.6%)
Dec 2019
-$26.22 M(+28.9%)
-$6.22 M(+27.6%)
-$26.22 M(+4.9%)
Sep 2019
-
-$4.88 M(-22.6%)
-$25.00 M(+4.1%)
Jun 2019
-
-$6.30 M(-28.5%)
-$24.01 M(-1.4%)
Mar 2019
-
-$8.82 M(+76.0%)
-$24.36 M(+19.8%)
Dec 2018
-$20.34 M(+174.3%)
-$5.01 M(+29.0%)
-$20.33 M(+19.8%)
Sep 2018
-
-$3.88 M(-41.6%)
-$16.98 M(+17.5%)
Jun 2018
-
-$6.65 M(+38.7%)
-$14.44 M(+58.2%)
Mar 2018
-
-$4.79 M(+190.0%)
-$9.13 M(+23.1%)
Dec 2017
-$7.42 M(-3.9%)
-$1.65 M(+22.2%)
-$7.42 M(-11.2%)
Sep 2017
-
-$1.35 M(+1.5%)
-$8.35 M(+3.5%)
Jun 2017
-
-$1.33 M(-56.7%)
-$8.07 M(-2.1%)
Mar 2017
-
-$3.08 M(+18.8%)
-$8.24 M(+6.9%)
Dec 2016
-$7.71 M(-14.2%)
-$2.59 M(+141.5%)
-$7.71 M(+0.2%)
Sep 2016
-
-$1.07 M(-28.6%)
-$7.70 M(-9.1%)
Jun 2016
-
-$1.50 M(-41.0%)
-$8.47 M(-6.4%)
Mar 2016
-
-$2.55 M(-1.2%)
-$9.05 M(+0.6%)
Dec 2015
-$8.99 M(-6.3%)
-$2.58 M(+40.2%)
-$8.99 M(-0.7%)
Sep 2015
-
-$1.84 M(-11.5%)
-$9.06 M(+1.0%)
Jun 2015
-
-$2.08 M(-16.6%)
-$8.97 M(-1.9%)
Mar 2015
-
-$2.49 M(-5.8%)
-$9.14 M(-4.8%)
Dec 2014
-$9.60 M(+1.9%)
-$2.65 M(+51.5%)
-$9.60 M(-0.9%)
Sep 2014
-
-$1.75 M(-22.4%)
-$9.68 M(-4.9%)
Jun 2014
-
-$2.25 M(-23.7%)
-$10.18 M(+0.9%)
Mar 2014
-
-$2.95 M(+8.2%)
-$10.08 M(+7.1%)
Dec 2013
-$9.42 M(+26.2%)
-$2.73 M(+21.6%)
-$9.42 M(+5.8%)
Sep 2013
-
-$2.24 M(+4.0%)
-$8.91 M(+5.2%)
Jun 2013
-
-$2.16 M(-5.7%)
-$8.47 M(+8.4%)
Mar 2013
-
-$2.29 M(+3.2%)
-$7.81 M(+5.7%)
Dec 2012
-$7.46 M(+13.8%)
-$2.22 M(+22.7%)
-$7.39 M(+4.7%)
Sep 2012
-
-$1.81 M(+20.4%)
-$7.06 M(-9.5%)
Jun 2012
-
-$1.50 M(-19.5%)
-$7.79 M(+4.2%)
Mar 2012
-
-$1.86 M(-1.1%)
-$7.48 M(+14.0%)
Dec 2011
-$6.56 M(+58.9%)
-$1.88 M(-25.9%)
-$6.56 M(-7.3%)
Sep 2011
-
-$2.54 M(+114.2%)
-$7.08 M(+41.0%)
Jun 2011
-
-$1.19 M(+25.9%)
-$5.02 M(+20.5%)
Mar 2011
-
-$943.50 K(-60.7%)
-$4.16 M(+16.0%)
Dec 2010
-$4.13 M(-125.8%)
-$2.40 M(+395.4%)
-$3.59 M(-124.1%)
Sep 2010
-
-$484.90 K(+45.7%)
$14.90 M(-2.4%)
Jun 2010
-
-$332.90 K(-10.0%)
$15.26 M(-3.0%)
Mar 2010
-
-$369.70 K(-102.3%)
$15.74 M(-1.5%)
Dec 2009
$15.98 M(-1645.8%)
$16.09 M(<-9900.0%)
$15.98 M(-7185.9%)
Sep 2009
-
-$126.00 K(-186.7%)
-$225.50 K(-66.8%)
Jun 2009
-
$145.30 K(-213.0%)
-$679.50 K(-32.1%)
Mar 2009
-
-$128.60 K(+10.7%)
-$1.00 M(-3.2%)
Dec 2008
-$1.03 M(+32.9%)
-$116.20 K(-80.0%)
-$1.03 M(+9.7%)
Sep 2008
-
-$580.00 K(+230.5%)
-$942.20 K(+14.1%)
Jun 2008
-
-$175.50 K(+8.4%)
-$825.90 K(+1.2%)
Mar 2008
-
-$161.90 K(+552.8%)
-$816.20 K(+5.0%)
Dec 2007
-$777.60 K(+109.1%)
-$24.80 K(-94.7%)
-$777.60 K(-11.5%)
Sep 2007
-
-$463.70 K(+179.7%)
-$878.80 K(+80.2%)
Jun 2007
-
-$165.80 K(+34.5%)
-$487.60 K(+11.1%)
Mar 2007
-
-$123.30 K(-2.1%)
-$438.90 K(+18.0%)
Dec 2006
-$371.90 K(+21.3%)
-$126.00 K(+73.8%)
-$371.90 K(+266.8%)
Sep 2006
-
-$72.50 K(-38.1%)
-$101.40 K(+131.0%)
Jun 2006
-
-$117.10 K(+108.0%)
-$43.90 K(-495.5%)
Mar 2006
-
-$56.30 K(-139.0%)
$11.10 K(-103.6%)
Dec 2005
-$306.50 K
$144.50 K(-1063.3%)
-$306.50 K(-58.2%)
DateAnnualQuarterlyTTM
Sep 2005
-
-$15.00 K(-75.8%)
-$732.70 K(-1420.2%)
Jun 2005
-
-$62.10 K(-83.4%)
$55.50 K(-333.2%)
Mar 2005
-
-$373.90 K(+32.7%)
-$23.80 K(-129.3%)
Dec 2004
-$97.70 K(-91.1%)
-$281.70 K(-136.4%)
$81.20 K(-109.6%)
Sep 2004
-
$773.20 K(-646.8%)
-$844.00 K(-46.1%)
Jun 2004
-
-$141.40 K(-47.4%)
-$1.57 M(-8.9%)
Mar 2004
-
-$268.90 K(-77.7%)
-$1.72 M(+7.3%)
Dec 2003
-$1.09 M(-41.5%)
-$1.21 M(-2457.2%)
-$1.60 M(+79.6%)
Sep 2003
-
$51.20 K(-117.4%)
-$891.90 K(-21.4%)
Jun 2003
-
-$294.10 K(+93.0%)
-$1.14 M(-19.4%)
Mar 2003
-
-$152.40 K(-69.3%)
-$1.41 M(-24.6%)
Dec 2002
-$1.87 M(-17.6%)
-$496.60 K(+158.5%)
-$1.87 M(+36.2%)
Sep 2002
-
-$192.10 K(-66.1%)
-$1.37 M(-15.1%)
Jun 2002
-
-$567.00 K(-7.2%)
-$1.61 M(-40.6%)
Mar 2002
-
-$611.00 K(+40.0%)
-$2.72 M(-16.2%)
Dec 2001
-$2.26 M(-9.1%)
-
-
Sep 2001
-
-$436.30 K(-73.9%)
-$3.24 M(+1.2%)
Jun 2001
-$2.49 M(+25.6%)
-$1.67 M(+1127.0%)
-$3.21 M(+48.3%)
Mar 2001
-
-$136.30 K(-86.4%)
-$2.16 M(-12.0%)
Dec 2000
-
-$999.30 K(+150.8%)
-$2.46 M(+25.5%)
Sep 2000
-
-$398.50 K(-36.6%)
-$1.96 M(-4.9%)
Jun 2000
-$1.98 M(+120.3%)
-$628.40 K(+46.2%)
-$2.06 M(+26.3%)
Mar 2000
-
-$429.90 K(-14.0%)
-$1.63 M(+16.4%)
Dec 1999
-
-$500.00 K(0.0%)
-$1.40 M(+7.7%)
Sep 1999
-
-$500.00 K(+150.0%)
-$1.30 M(+62.5%)
Jun 1999
-$900.00 K(-325.0%)
-$200.00 K(0.0%)
-$800.00 K(+33.3%)
Mar 1999
-
-$200.00 K(-50.0%)
-$600.00 K(+20.0%)
Dec 1998
-
-$400.00 K(<-9900.0%)
-$500.00 K(<-9900.0%)
Sep 1998
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 1998
$400.00 K(-63.6%)
$0.00(-100.0%)
$400.00 K(-50.0%)
Mar 1998
-
-$100.00 K(-200.0%)
$800.00 K(-33.3%)
Dec 1997
-
$100.00 K(-75.0%)
$1.20 M(+9.1%)
Sep 1997
-
$400.00 K(0.0%)
$1.10 M(+10.0%)
Jun 1997
$1.10 M(+120.0%)
$400.00 K(+33.3%)
$1.00 M(+11.1%)
Mar 1997
-
$300.00 K(>+9900.0%)
$900.00 K(-18.2%)
Dec 1996
-
$0.00(-100.0%)
$1.10 M(+83.3%)
Sep 1996
-
$300.00 K(0.0%)
$600.00 K(0.0%)
Jun 1996
$500.00 K(-44.4%)
$300.00 K(-40.0%)
$600.00 K(+200.0%)
Mar 1996
-
$500.00 K(-200.0%)
$200.00 K(0.0%)
Dec 1995
-
-$500.00 K(-266.7%)
$200.00 K(-77.8%)
Sep 1995
-
$300.00 K(-400.0%)
$900.00 K(+12.5%)
Jun 1995
$900.00 K(-35.7%)
-$100.00 K(-120.0%)
$800.00 K(-27.3%)
Mar 1995
-
$500.00 K(+150.0%)
$1.10 M(+22.2%)
Dec 1994
-
$200.00 K(0.0%)
$900.00 K(-10.0%)
Sep 1994
-
$200.00 K(0.0%)
$1.00 M(-28.6%)
Jun 1994
$1.40 M(+16.7%)
$200.00 K(-33.3%)
$1.40 M(-12.5%)
Mar 1994
-
$300.00 K(0.0%)
$1.60 M(0.0%)
Dec 1993
-
$300.00 K(-50.0%)
$1.60 M(+14.3%)
Sep 1993
-
$600.00 K(+50.0%)
$1.40 M(+16.7%)
Jun 1993
$1.20 M(-20.0%)
$400.00 K(+33.3%)
$1.20 M(+9.1%)
Mar 1993
-
$300.00 K(+200.0%)
$1.10 M(-8.3%)
Dec 1992
-
$100.00 K(-75.0%)
$1.20 M(-20.0%)
Sep 1992
-
$400.00 K(+33.3%)
$1.50 M(0.0%)
Jun 1992
$1.50 M(+7.1%)
$300.00 K(-25.0%)
$1.50 M(-6.3%)
Mar 1992
-
$400.00 K(0.0%)
$1.60 M(+14.3%)
Dec 1991
-
$400.00 K(0.0%)
$1.40 M(+7.7%)
Sep 1991
-
$400.00 K(0.0%)
$1.30 M(0.0%)
Jun 1991
$1.40 M(+55.6%)
$400.00 K(+100.0%)
$1.30 M(-165.0%)
Mar 1991
-
$200.00 K(-33.3%)
-$2.00 M(<-9900.0%)
Dec 1990
-
$300.00 K(-25.0%)
$0.00(-100.0%)
Sep 1990
-
$400.00 K(-113.8%)
$1.20 M(+9.1%)
Jun 1990
$900.00 K(-10.0%)
-$2.90 M(-231.8%)
$1.10 M(-1200.0%)
Mar 1990
-
$2.20 M(+46.7%)
-$100.00 K(-85.7%)
Dec 1989
-
$1.50 M(+400.0%)
-$700.00 K(+40.0%)
Sep 1989
-
$300.00 K(-107.3%)
-$500.00 K(-171.4%)
Jun 1989
$1.00 M(-23.1%)
-$4.10 M(-356.3%)
$700.00 K(-56.3%)
Mar 1989
-
$1.60 M(-5.9%)
$1.60 M(+14.3%)
Dec 1988
-
$1.70 M(+13.3%)
$1.40 M(+27.3%)
Sep 1988
-
$1.50 M(-146.9%)
$1.10 M(+10.0%)
Jun 1988
$1.30 M(+85.7%)
-$3.20 M(-328.6%)
$1.00 M(-9.1%)
Mar 1988
-
$1.40 M(0.0%)
$1.10 M(+22.2%)
Dec 1987
-
$1.40 M(0.0%)
$900.00 K(+28.6%)
Sep 1987
-
$1.40 M(-145.2%)
$700.00 K(+40.0%)
Jun 1987
$700.00 K
-$3.10 M(-358.3%)
$500.00 K(-86.1%)
Mar 1987
-
$1.20 M(0.0%)
$3.60 M(+50.0%)
Dec 1986
-
$1.20 M(0.0%)
$2.40 M(+100.0%)
Sep 1986
-
$1.20 M
$1.20 M

FAQ

  • What is AxoGen annual EBITDA?
  • What is the all time high annual EBITDA for AxoGen?
  • What is AxoGen annual EBITDA year-on-year change?
  • What is AxoGen quarterly EBITDA?
  • What is the all time high quarterly EBITDA for AxoGen?
  • What is AxoGen quarterly EBITDA year-on-year change?
  • What is AxoGen TTM EBITDA?
  • What is the all time high TTM EBITDA for AxoGen?
  • What is AxoGen TTM EBITDA year-on-year change?

What is AxoGen annual EBITDA?

The current annual EBITDA of AXGN is -$13.33 M

What is the all time high annual EBITDA for AxoGen?

AxoGen all-time high annual EBITDA is $15.98 M

What is AxoGen annual EBITDA year-on-year change?

Over the past year, AXGN annual EBITDA has changed by +$10.14 M (+43.22%)

What is AxoGen quarterly EBITDA?

The current quarterly EBITDA of AXGN is $2.00 M

What is the all time high quarterly EBITDA for AxoGen?

AxoGen all-time high quarterly EBITDA is $16.09 M

What is AxoGen quarterly EBITDA year-on-year change?

Over the past year, AXGN quarterly EBITDA has changed by $0.00 (0.00%)

What is AxoGen TTM EBITDA?

The current TTM EBITDA of AXGN is $1.72 M

What is the all time high TTM EBITDA for AxoGen?

AxoGen all-time high TTM EBITDA is $15.98 M

What is AxoGen TTM EBITDA year-on-year change?

Over the past year, AXGN TTM EBITDA has changed by $0.00 (0.00%)